Tool for Inappropriate Prescription Evaluation: The TaIPE Study

Last updated: July 22, 2019
Sponsor: Centre Hospitalier Universitaire Vaudois
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04028583
TaIPE
  • Ages > 65
  • All Genders

Study Summary

A mono-center, randomized controlled trial will be conducted at the University Hospital of Lausanne. Hospitalized patients will be randomly assigned from the emergency department to two sub-units composing the acute care for elders (ACE) unit. In one subunit, potentially inappropriate prescriptions will be detected and treatment optimized according PIM-Check. In the other, STOPP/START criteria will be independently applied.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients meeting the admission criteria of the acute care for elders (ACE) unitwill be eligible.

Exclusion

Exclusion Criteria:

  • none

Study Design

Total Participants: 464
Study Start date:
February 26, 2018
Estimated Completion Date:
August 04, 2019

Connect with a study center

  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Vaud 1011
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.